Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Sales | 3,594,019 | 2,838,666 | 2,525,087 | 2,371,069 |
| Gross Profit | 3,594,019 | 2,838,666 | 2,525,087 | 2,371,069 |
| Operating Income | 3,594,019 | 2,838,666 | 2,525,087 | 2,371,069 |
| Pre-tax Income | 3,594,019 | 2,838,666 | 2,525,087 | 2,371,069 |
| Net Income Continuous | 704,847 | -921,576 | 583,432 | 274,836 |
| Net Income | $704,847 | $-921,576 | $583,432 | $274,836 |
| EPS Basic Total Ops | 0.44 | -0.47 | 0.34 | 0.15 |
| EPS Basic Continuous Ops | 0.44 | -0.48 | 0.34 | 0.15 |
| EPS Diluted Total Ops | 0.44 | -0.47 | 0.34 | 0.15 |
| EPS Diluted Continuous Ops | 0.44 | -0.48 | 0.34 | 0.15 |
| EBITDA(a) | $3,594,019 | $2,838,666 | $2,525,087 | $2,371,069 |